HNB
AMPH icon

Huntington National Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

Huntington National Bank’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-191
Closed -$5.12K – 4213
2025
Q4 		$5.12K Sell
191
-80
-30% -$2.06K ﹤0.01% 1989
2025
Q3 		$7.22K Buy
271
+18
+7% +$465 ﹤0.01% 1916
2025
Q2 		$5.81K Sell
253
-371
-59% -$9.21K ﹤0.01% 1954
2025
Q1 		$18.1K Sell
624
-716
-53% -$22.9K ﹤0.01% 1557
2024
Q4 		$49.8K Buy
1,340
+361
+37% +$16.5K ﹤0.01% 1201
2024
Q3 		$47.5K Buy
979
+90
+10% +$3.95K ﹤0.01% 1198
2024
Q2 		$35.6K Buy
889
+56
+7% +$2.32K ﹤0.01% 1261
2024
Q1 		$36.6K Buy
833
+72
+9% +$3.72K ﹤0.01% 1240
2023
Q4 		$47.1K Buy
761
+516
+211% +$27.1K ﹤0.01% 1100
2023
Q3 		$11.3K Buy
245
+28
+13% +$1.53K ﹤0.01% 1525
2023
Q2 		$12.5K Sell
217
-212
-49% -$9.4K ﹤0.01% 1500
2023
Q1 		$16.1K Sell
429
-23
-5% -$754 ﹤0.01% 1404
2022
Q4 		$12.7K Buy
452
+41
+10% +$1.19K ﹤0.01% 1425
2022
Q3 		$12K Buy
411
+325
+378% +$10.6K ﹤0.01% 1468
2022
Q2 		$3K Buy
+86
New +$3.07K ﹤0.01% 1806

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Huntington National Bank's AMPH Position: Q1 2026 in Review

Huntington National Bank sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 191 shares — an estimated $5.12K sold.

Huntington National Bank first reported a position in AMPH in Q2 2022 and held it in 15 quarters. The position peaked at $49.8K in Q4 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Huntington National Bank reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Huntington National Bank sold 191 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $5.12K.
  • Huntington National Bank first reported a position in Amphastar Pharmaceuticals in Q2 2022 and held it in 15 quarters.
  • Huntington National Bank's Amphastar Pharmaceuticals position peaked at $49.8K in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.